Cabenuva (Generic Cabotegravir-Rilpivirine): Complete Medication Guide
Key Takeaways
Cabenuva is a long-acting injectable combination HIV medication given as a two-drug injection once monthly after an initial oral lead-in period.
It combines cabotegravir (an integrase inhibitor) and rilpivirine (a non-nucleoside reverse transcriptase inhibitor) to suppress HIV replication.
Common side effects include injection site reactions, headache, and fatigue, while serious side effects are rare but may include liver problems.
It requires consistent monthly appointments and is best suited for people with undetectable viral loads who want to simplify their HIV treatment routine.
Discuss with your healthcare provider whether Cabenuva is right for your individual HIV management plan.
Cabenuva Overview
Cabenuva is a long-acting injectable combination medication used to treat HIV-1 infection in people whose virus is already suppressed on other antiretroviral therapies. It contains two active ingredients: cabotegravir and rilpivirine. Cabotegravir belongs to a class of drugs called integrase inhibitors, which work by blocking the integrase enzyme that HIV uses to insert its genetic material into human cells. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that stops HIV from copying itself.
Unlike daily oral HIV medications, Cabenuva offers a simpler treatment schedule: after a 1-month oral lead-in period with cabotegravir and rilpivirine tablets, patients receive two intramuscular injections once per month. This approach may improve medication adherence and quality of life for people managing a chronic condition. The generic version of Cabenuva contains the same active ingredients as the brand name and works in the same way, making it a cost-effective alternative to brand-name drugs for many people.
Cabenuva is designed for people with HIV-1 who have an undetectable viral load (fewer than 50 copies per milliliter of blood) while on their current treatment. It is not meant for people who are newly diagnosed or whose virus is not yet under control, as it requires a period of viral suppression before starting the injections.
Side Effects
Most people tolerate Cabenuva well, though like all medications, it can cause side effects. The majority are mild to moderate and improve with time.
Common Side Effects
Injection site reactions: Soreness, redness, swelling, or bruising at the injection site lasting a few days after the shot
Headache: Mild to moderate headaches that may occur shortly after injection or during treatment
Fatigue or tiredness: Low energy levels or general weakness
Nausea: Stomach upset or mild queasiness that typically subsides
Fever or chills: Low-grade fever or mild chills occurring within 24 hours of injection
Diarrhea or constipation: Changes in bowel habits
Serious Side Effects
Liver problems: Elevated liver enzymes or signs of hepatotoxicity, especially in people with hepatitis B or C coinfection
Hypersensitivity reactions: Severe allergic reactions including rash, fever, and swelling that require immediate medical attention
Psychiatric effects: Depression, suicidal thoughts, or mood changes reported in some patients
Resistance development: HIV resistance if doses are missed or therapy is stopped abruptly
Immune reconstitution inflammatory syndrome (IRIS): Worsening of certain infections as the immune system recovers
When to Seek Medical Attention
Contact your healthcare provider right away if you experience severe injection site reactions that don't improve after a few days, signs of liver problems such as yellowing of skin or eyes or dark urine, or any signs of a serious allergic reaction including difficulty breathing or facial swelling.
If you develop new psychiatric symptoms, thoughts of self-harm, or notice your viral load is no longer undetectable, notify your doctor promptly. Missing doses or stopping treatment without medical supervision increases the risk of treatment failure and drug resistance, so consistent adherence to your injection schedule is critical.
Dosage
Dose Level or Form |
Dose |
Key Detail |
Oral Lead-In Phase |
Cabotegravir 30 mg once daily + Rilpivirine 25 mg once daily |
Take with food; lasts 1 month to assess tolerability |
Monthly Injection (Maintenance) |
Cabotegravir 400 mg + Rilpivirine 300 mg |
Given as two separate gluteal intramuscular injections on the same day, then monthly thereafter |
Extended Interval Option |
Cabotegravir 600 mg + Rilpivirine 900 mg |
Administered every 2 months in select patients with consistent viral suppression and tolerability |
Important: Never skip or delay your scheduled injections without discussing it with your doctor first. Missing doses can lead to viral rebound and treatment resistance. If you miss an injection, contact your healthcare provider immediately to reschedule. Do not stop treatment without medical guidance, as abrupt discontinuation increases the risk of drug resistance and treatment failure.
Drug Interactions
Cabenuva can interact with several medications and supplements, potentially reducing its effectiveness or increasing the risk of side effects. Always inform your healthcare provider about all medications, herbal products, and supplements you are taking.
Proton Pump Inhibitors (PPIs) and H2-Blockers
Medications like omeprazole or famotidine reduce the absorption of rilpivirine in the stomach, lowering drug levels in your blood and potentially reducing its effectiveness. If you need acid-reducing medications, discuss alternatives or timing with your doctor.
Rifampin and Rifabutin
These tuberculosis medications significantly reduce levels of both cabotegravir and rilpivirine, making Cabenuva less effective. These combinations are generally not recommended; your doctor may need to switch you to alternative HIV or TB medications.
St. John's Wort
This herbal supplement induces liver enzymes that break down both active ingredients, substantially decreasing Cabenuva levels. Avoid this supplement while taking Cabenuva, as it can lead to treatment failure.
Anticonvulsants (Phenytoin, Carbamazepine)
Seizure medications increase the metabolism of cabotegravir and rilpivirine, lowering their effectiveness. Your doctor may need to adjust doses or switch to alternative seizure medications.
Certain Antiretrovirals
Other HIV medications like dolutegravir or efavirenz may interact with Cabenuva components. Switching to Cabenuva requires careful timing and monitoring by your HIV specialist.
Metoclopramide
This anti-nausea medication can reduce rilpivirine absorption. If nausea is an issue, discuss alternative anti-nausea options with your healthcare provider.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Simplified treatment schedule: Only one injection per month (or every two months with extended-interval dosing) eliminates the burden of daily pill-taking
Improved adherence potential: Fewer missed doses mean better viral suppression and reduced resistance risk over time
Long-acting formulation: Cabotegravir and rilpivirine are slowly released from injection sites, maintaining stable drug levels throughout the month
Proven effectiveness: Clinical trials show Cabenuva maintains viral suppression as effectively as daily oral medications in people with undetectable viral loads
Quality of life improvement: Many people report better mental health and lifestyle flexibility with monthly injections versus daily pills
Cons
Injection-related discomfort: Injection site pain, swelling, or redness can be bothersome and may persist for days
Commitment to appointments: Missing a monthly appointment can lead to viral rebound, unlike daily pills that offer some flexibility
Limited flexibility: Once you start, you must continue monthly appointments; missing doses is riskier than with daily oral medications
Higher upfront cost: Injectable medications are often more expensive initially, though save money on generic drugs for high blood pressure and cholesterol may apply to some patient assistance programs
Not suitable for all people: Cabenuva only works for people with undetectable viral loads; those with detectable virus must use other regimens first
Frequently Asked Questions
Get answers to common questions about Cabenuva.
Yes, if your viral load is undetectable (below 50 copies/mL) on your current HIV regimen. You'll complete a 1-month oral lead-in phase to confirm tolerability before starting monthly injections. Discuss timing and whether a switch makes sense for your situation with your HIV specialist.
Missing a dose increases your risk of viral rebound and developing drug resistance. Contact your healthcare provider immediately to reschedule. Depending on how long since your last injection, your doctor may recommend a different medication temporarily or an urgent catch-up injection. Do not attempt to double-dose.
The active ingredients are identical, and generic vs. brand-name drugs are bioequivalent under FDA oversight. Cost savings are typically significant with generics. Both are equally effective, though insurance or patient assistance programs may vary.
Most people report mild to moderate discomfort during the injection, similar to a flu shot. Pain and soreness at the injection site usually subside within 24–48 hours. Ice before and after injection and alternating injection sites between visits may reduce discomfort.
Seek emergency medical care immediately by calling 911 or going to the nearest emergency room. Inform the medical team that you've received Cabenuva injections. Severe reactions are rare but can include difficulty breathing, facial or throat swelling, or severe rash. Never attempt to treat a severe allergic reaction at home.
The Bottom Line
Cabenuva is a long-acting injectable combination HIV medication that offers a simpler, once-monthly treatment option for people whose virus is already suppressed. By combining cabotegravir and rilpivirine, it provides effective viral suppression while reducing the daily medication burden many people face. The generic version delivers the same active ingredients at a lower cost, making it accessible to more people living with HIV. However, it requires strong commitment to monthly appointments and is only suitable for people with undetectable viral loads. Common side effects like injection site reactions and headache are usually mild, while serious complications are rare with proper monitoring. If you're considering Cabenuva or any HIV treatment, Doctronic offers 24/7 access to medical guidance—get a free AI consultation or connect with a doctor via video or text chat in minutes. Ready to simplify your HIV management? Start with Doctronic today.
